Baidu
map

呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版）

2014-01-30 中国呼吸科专家组（统称） 国际呼吸杂志.2014,34(1):1-11.

COPD

慢性阻塞性肺疾病(chronic obstructive pulmonary disease，COPD)简称慢阻肺，是一种严重危害人类健康的常见病、多发病。慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组制定了慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版），是对前一版的修订。

中文标题：

慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版）

发布机构：

中国呼吸科专家组（统称）

发布日期：

2014-01-30

简要介绍：

慢性阻塞性肺疾病(chronic obstructive pulmonary disease，COPD)简称慢阻肺，是一种严重危害人类健康的常见病、多发病。慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组制定了慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版），是对前一版的修订。

相关资料下载：
[AttachmentFileName(sort=100, fileName=慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版）)] GetToolGuiderByIdResponse(projectId=1, id=236a51c0010a58cb, title=慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版）, enTitle=, guiderFrom=国际呼吸杂志.2014,34(1):1-11., authorId=null, author=, summary=慢性阻塞性肺疾病(chronic obstructive pulmonary disease，COPD)简称慢阻肺，是一种严重危害人类健康的常见病、多发病。慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组制定了慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版），是对前一版的修订。, cover=, journalId=null, articlesId=null, associationId=745, associationName=中国呼吸科专家组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jan 30 08:00:00 CST 2014, originalUrl=http://guide.medlive.cn/guideline/5699, linkOutUrl=, content=慢性阻塞性肺疾病(chronic obstructive pulmonary disease，COPD)简称慢阻肺，是一种严重危害人类健康的常见病、多发病。慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组制定了慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版），是对前一版的修订。, tagList=[TagDto(tagId=295, tagName=COPD)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3475, appHits=478, showAppHits=0, pcHits=2207, showPcHits=1121, likes=160, shares=16, comments=3, approvalStatus=1, publishedTime=Thu Jan 30 00:00:00 CST 2014, publishedTimeString=2014-01-30, pcVisible=1, appVisible=1, editorId=null, editor=milly, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=null, createdTime=Thu Jan 30 00:00:00 CST 2014, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 18:59:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版）)])
慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识（2014年修订版）
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=947681, encodeId=214894e6812e, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb895465274, createdName=ms9000000887493171, createdTime=Fri Mar 12 15:49:47 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920422, encodeId=56df92042259, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e395434487, createdName=ms8000000926639308, createdTime=Wed Jan 27 20:57:31 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156421, encodeId=aa8c156421b0, content=值得学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70a41414118, createdName=copdgy, createdTime=Thu Nov 17 14:08:20 CST 2016, time=2016-11-17, status=1, ipAttribution=)]
    2021-03-12 ms9000000887493171

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=947681, encodeId=214894e6812e, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb895465274, createdName=ms9000000887493171, createdTime=Fri Mar 12 15:49:47 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920422, encodeId=56df92042259, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e395434487, createdName=ms8000000926639308, createdTime=Wed Jan 27 20:57:31 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156421, encodeId=aa8c156421b0, content=值得学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70a41414118, createdName=copdgy, createdTime=Thu Nov 17 14:08:20 CST 2016, time=2016-11-17, status=1, ipAttribution=)]
    2021-01-27 ms8000000926639308

    非常感谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=947681, encodeId=214894e6812e, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb895465274, createdName=ms9000000887493171, createdTime=Fri Mar 12 15:49:47 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920422, encodeId=56df92042259, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e395434487, createdName=ms8000000926639308, createdTime=Wed Jan 27 20:57:31 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156421, encodeId=aa8c156421b0, content=值得学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70a41414118, createdName=copdgy, createdTime=Thu Nov 17 14:08:20 CST 2016, time=2016-11-17, status=1, ipAttribution=)]
    2016-11-17 copdgy

    值得学习！

    0

相关指南

2015 GOLD 慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略（更新版）

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2014-01-17

2013 西班牙COPD指南：慢性阻塞性肺疾病基于临床表型的分级和治疗

西班牙肺病和胸外科学会(SEPAR,Spanish Society of Pneumology and Thoracic Surgery) · 2013-03-20

2013 GOLD 慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略（修订版）

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2013-02-13

慢性阻塞性肺疾病急性加重（AECOPD）诊治中国专家共识（草案）

中国呼吸科专家组（统称） · 2012-11-01

2011 GOLD 慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2011-12-01

2010JRS 日本呼吸学会慢性阻塞性肺疾病（COPD）诊治指南(概述)

日本呼吸学会(JRS,the Japanese Respiratory Society) · 2010-02-01

Baidu
map
Baidu
map
Baidu
map